Daniel Cressy

Daniel Cressy 是一位美国患者倡导者和有志于成为商业飞行员的人，他成为路易斯安那州和美国东南部第一位接受镰状细胞病基因治疗的人。2026年3月成功的治疗在功能上治愈了他从出生就患有的遗传性血液疾病。Cressy 共同创立了非营利组织 Privileged Pilots，帮助其他镰状细胞病患者追求航空事业，并正在撰写一本关于他旅程的书，书名为《天空的祝福》。他的故事引起了全国关注，NOLA.com 和 Verite News 等媒体进行了报道，并在由路易斯安那州州长 Jeff Landry 出席的敲钟仪式上受到表彰。[编辑]

Daniel Cressy 在路易斯安那州的梅泰里长大，从出生起就与镰状细胞病作斗争。这种疾病导致周期性疼痛危机，有时使他无法上学和进行日常活动。19岁时，他在2022年11月进行了一次发现飞行，并立即爱上了航空。他开始上飞行课，立志成为一名商业飞行员。但当他向 FAA 申请一级体检合格证时，因镰状细胞病诊断而被拒绝。2023年的那次拒绝成为了转折点。Cressy 了解到，如果他能通过骨髓移植或基因治疗治愈疾病，FAA 会重新考虑。他开始研究刚刚获批临床试验的基因治疗，并与 Manning Family Children's Hospital 和 Tulane 镰状细胞中心的医生讨论了治疗方案。[编辑]

2023年5月，Cressy 开始积极寻求基因治疗作为成为飞行员的途径。他的干细胞于2025年7月30日在新奥尔良的 Manning Family Children's Hospital 采集，并送往欧洲进行 DNA 编辑。2026年3月9日，他入院接受治疗。他于3月11日至14日接受化疗以准备身体，并于2026年3月18日接受了修改后的干细胞输注。这一天使他成为路易斯安那州和美国东南部第一位接受镰状细胞病基因治疗的患者。2026年6月22日，Cressy 在医院敲响了钟，标志着他功能上的治愈。医生确认该疾病已不再活跃于他的体内。他与 Kyle Registre 共同创立了 Privileged Pilots，后者于2019年治愈了 SCD，并于2025年6月2日成为第一位获得证书的患有 SCD 的飞行员。Cressy 现在有资格恢复飞行训练，并正在撰写一本关于他经历的书。[编辑]

Daniel Cressy 被媒体描绘为一个坚定而有韧性的年轻人，他拒绝让慢性疾病阻碍他飞行的梦想。新闻报道强调了他的勇气、历史性的医疗成就以及对镰状细胞病患者的倡导。他说话时带着感激和决心，经常强调只要下定决心，你就能做任何事。他的故事激励了镰状细胞病社区、航空爱好者和医疗倡导团体。他没有粉丝名称或标志性时尚风格；他的公众形象是一位患者倡导者和有志飞行员。[编辑]

Daniel Cressy has not yet been assigned a global or category-specific ranking by the iFANN Editorial Team as of August 2026. The Fame Engine has not collected sufficient data to place him among the most famous individuals in the world, nor has it determined his standing within any specific genre or demographic. While his medical milestone generated significant regional attention and national news coverage, this does not translate into a quantifiable fame score at this time. Consequently, no ordinal rank is currently associated with his name in the database. His public profile remains defined by his status as a patient advocate and the first person in Louisiana to receive a functional cure for sickle cell disease through gene therapy rather than by celebrity metrics. There is no documented formal fandom name, organized fan groups, or grassroots campaigns initiated by a following. Unlike entertainers who cultivate dedicated communities with specific rituals or hashtags, Cressy's supporters are primarily drawn from the medical community, local residents, and those following the progress of sickle cell treatments. The Manning Family Children's Hospital and various news outlets have provided support, but these entities do not constitute a fanbase in the traditional sense. No subway advertisements, streaming pushes, or viral entertainment incidents have emerged to create a distinct cultural footprint beyond the initial news cycle. The absence of a named fandom reflects the nature of his achievement as a singular medical event rather than a performance career designed for mass consumption. Until his story evolves into a broader cultural phenomenon with measurable engagement signals, he remains outside the ranked scope of the system.[编辑]

Daniel Cressy refers to March 18, 2026, the date of his stem cell infusion, as his second birthday. To prepare for the gene therapy, he underwent chemotherapy for four days. His stem cells were harvested on July 30, 2025, transported to Europe for DNA editing, and subsequently re-infused. Approximately 3,000 people in Louisiana live with sickle cell disease. Cressy has noted that access to treatment should not depend on one's zip code. His friend and co-founder Kyle Registre was cured of SCD in 2019 via a BlueBird Bio clinical trial and became the first pilot with SCD to earn his certificate on June 2, 2025. On June 22, 2026, Cressy rang a bell at the Manning Family Children's Hospital in New Orleans, an event captured by NOLA.com that symbolized his transition from chronic illness to health. This ceremony marked the culmination of a two-year journey where he had previously faced hospitalization six to twelve times annually due to complications. The successful treatment using Casgevy gene therapy stands as a verified medical landmark for the Gulf South region. Cressy plans to pursue his dream of becoming a commercial pilot and has authored a book titled Blessing in the Skies about his experiences.[编辑]

Daniel Cressy 在新奥尔良地区出生和长大，具体在路易斯安那州的梅泰里。关于他父母或兄弟姐妹的详细信息尚未公开分享。他通过 Tulane 镰状细胞中心和 Manning Family Children's Hospital 接受医疗护理。截至2026年，他居住在路易斯安那州，专注于他的倡导工作、飞行训练和撰写书籍。[编辑]

没有关于 Daniel Cressy 恋爱关系的公开信息。截至2026年，没有关于现任或前任伴侣、订婚或婚姻的可靠报道。他的公众形象完全集中在医疗旅程、非营利工作和航空抱负上。[编辑]

Daniel Cressy's net worth remains unrecorded in public financial disclosures as of 2026. The iFANN Editorial Team's research indicates that his primary professional identity centers on patient advocacy and aviation training rather than commercial entertainment or corporate leadership, a distinction that typically results in minimal public financial reporting for individuals at this stage of their careers. While he co-founded the nonprofit Privileged Pilots to support sickle cell patients pursuing aviation careers, the organization does not publish revenue figures, and no specific salary or compensation data is available for its founder. His current income streams appear limited to potential speaking engagements related to his medical advocacy and gene therapy journey, though no contracts or fees have been disclosed. He is currently authoring a book titled Blessing in the Skies, but terms regarding advances or royalties remain private. No real estate holdings, investment portfolios, or endorsement agreements have been verified through available records.[编辑]

Daniel Cressy 未获得传统娱乐或专业奖项。2026年，他因通过基因疗法成为路易斯安那州首位功能性治愈镰状细胞病的患者而获得认可，并在 Manning Family Children's Hospital 举办的敲钟仪式上受到表彰，州和地方官员出席了仪式。[编辑]